UK NSC seminars
Updated 31 March 2025
漏 Crown copyright 2025
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: [email protected].
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at /government/publications/uk-national-screening-committee-seminars/uk-nsc-seminars
1. Overview
The UK National Screening Committee (UK NSC) hosts seminars for stakeholders to learn from leading experts and to discuss important screening topics.
These events are held over Microsoft Teams and are free to attend. Details of future scheduled seminars are provided below.
2. Upcoming events
There are no upcoming events.
3. Past events
3.1 Multi-cancer detection tests and their implications for screening
This seminar was held on Thursday 27 February 2025. It explored multi-cancer detection tests (MCDs) and their potential use in a screening context.
The event was chaired by Prof Anne Mackie, UK NSC director of Programmes, and featured presentations from Dr Jessica Lloyd, strategic evidence manager within Cancer Research UK鈥檚 Evidence and Implementation Department, and UK NSC public health registrar Dr Tom Callender. The presentations were followed by a panel Q&A session.
See for a summary of the event and to view the presentations.
3.2 Polygenic scores
This seminar was held on Tuesday 6 February, 2024. Professor Anneke Lucassen, Director of the Centre for Personalised Medicine, University of Oxford, presented a discussion of the potential benefits and limitations of using polygenic scores to calculate the overall risk of developing a disease or condition.
See for a summary of the event and to view the presentation.
3.3 Planning and implementing an in-service evaluation
This seminar was held on 13 November, 2023, and looked at the process of planning and running an in-service evaluation (ISE). Presenters drew from the real-world context of the ISE of screening for severe combined immunodeficiency (SCID) as part of the NHS Newborn Blood Spot (NBS) Screening Programme in England.
See for summary of the event and to view the presentations.
3.4 Developing a clinical pathway for modelling of targeted lung cancer screening
This seminar was held on 31 October, 2023, and looked in detail at the evidence and the processes the UK NSC followed in developing a clinical pathway for the modelling of targeted lung cancer screening.
See for summary of the event and to view the presentations.